Skip to Content

CA3 (Lamotrigine (Chewable, Dispersible) 5 mg)

Pill imprint CA3 has been identified as Lamotrigine (chewable, dispersible) 5 mg.

Lamotrigine is used in the treatment of bipolar disorder; anxiety; schizoaffective disorder; borderline personality disorder; seizure prevention (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamotrigine (chewable, dispersible)
Imprint:
CA3
Strength:
5 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Jubilant Cadista Pharmaceuticals Inc.
National Drug Code (NDC):
59746-0311
Inactive Ingredients:
aspartame
acesulfame potassium
silicon dioxide
mannitol
microcrystalline cellulose
magnesium stearate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide